Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Review of Respiratory Medicine|March 10, 2023
Alpha-1 antitrypsin deficiency: current therapy and emerging targetsOisín F McElvaney, Daniel D Fraughen, Oliver J McElvaney, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 11, 2022
Attitudes Towards Vaccination for Coronavirus Disease 2019 in Patients with Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.Thorax|November 25, 2024
Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiencyMalcolm Herron, Suzanne Roche, Daniel D Fraughen, et al.Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|September 7, 2023
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin DeficiencyOliver J McElvaney, Brian Cleary, Daniel D Fraughen, et al.American Journal of Respiratory and Critical Care Medicine|August 25, 2023
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry AnalysisDaniel D Fraughen, Auyon J Ghosh, Brian D Hobbs, et al.Med (New York, N.Y.)|March 16, 2022
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)Malin Fromme, Karim Hamesch, Carolin V Schneider, et al.Pageof 1